A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA
Clinical trial NCT01078597 · COMPLETED
Trial details
- NCT number
- NCT01078597
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-07-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.